JBC PeproTech; Our Business is Cytokines!

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M501730200 on May 24, 2005

J. Biol. Chem., Vol. 280, Issue 29, 27138-27146, July 22, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
280/29/27138    most recent
M501730200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pozzi, A.
Right arrow Articles by Capdevila, J. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pozzi, A.
Right arrow Articles by Capdevila, J. H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Characterization of 5,6- and 8,9-Epoxyeicosatrienoic Acids (5,6- and 8,9-EET) as Potent in Vivo Angiogenic Lipids*

Ambra Pozzi{ddagger}§¶||, Ines Macias-Perez§, Tristin Abair§, Shouzuo Wei{ddagger}, Yan Su{ddagger}, Roy Zent{ddagger}§**, John R. Falck{ddagger}{ddagger}, and Jorge H. Capdevila{ddagger}§§

From the {ddagger}Division of Nephrology, Department of Medicine and Departments of §Cancer Biology and §§Biochemistry, Vanderbilt University Medical Center, Nashville, Tennessee 37232, the Veterans Affairs Hospital, Nashville, Tennessee 37212, and the {ddagger}{ddagger}Departments of Biochemistry and Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas 75390

The cytochrome P450 arachidonic acid epoxygenase metabolites, the epoxyeicosatrienoic acids (EETs) are powerful, nonregioselective, stimulators of cell proliferation. In this study we compared the ability of the four EETs (5,6-, 8,9-, 11,12-, and 14,15-EETs) to regulate endothelial cell proliferation in vitro and angiogenesis in vivo and determined the molecular mechanism by which EETs control these events. Inhibition of the epoxygenase blocked serum-induced endothelial cell proliferation, and exogenously added EETs rescued cell proliferation from epoxygenase inhibition. Studies with selective ERK, p38 MAPK, or PI3K inhibitors revealed that whereas activation of p38 MAPK is required for the proliferative responses to 8,9- and 11,12-EET, activation of PI3K is necessary for the cell proliferation induced by 5,6- and 14,15-EET. Among the four EETs, only 5,6- and 8,9-EET are capable of promoting endothelial cell migration and the formation of capillary-like structures, events that are dependent on EET-mediated activation of ERK and PI3K. Using subcutaneous sponge models, we showed that 5,6- and 8,9-EET are pro-angiogenic in mice and that their neo-vascularization effects are enhanced by the co-administration of an inhibitor of EET enzymatic hydration, presumably because of reduced EET metabolism and inactivation. These studies identify 5,6- and 8,9-EET as powerful and selective angiogenic lipids, provide a functional link between the EET proliferative chemotactic properties and their angiogenic activity, and suggest a physiological role for them in angiogenesis and de novo vascularization.


Received for publication, February 15, 2005 , and in revised form, April 29, 2005.

* These studies were supported in part by United States Public Health Service/National Institutes of Health Grants CA94849-01 (to A. P.), GM 37922 (to J. H. C.), DK069921 (to R. Z), GM31278 (to J. R. F.), Robert A. Welch Foundation, and by Vanderbilt University Mass Spectrometry Center, supported in part by Cancer Center Grant CA-68485. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

** Supported by an Advanced Career Development and Merit award from the Veterans Administration, an American Heart Association grant in aid award, and a Clinician Scientist award from NKF.

|| To whom correspondence should be addressed: Dept. of Medicine, Div. of Nephrology and Hypertension, Vanderbilt University, Medical Center N., B3109, Nashville, TN 37215. Tel.: 615-322-4537; Fax: 615-322-4690; E-mail: ambra.pozzi{at}vanderbilt.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
M. Terashvili, L. F. Tseng, H.-e. Wu, J. Narayanan, L. M. Hart, J. R. Falck, P. F. Pratt, and D. R. Harder
Antinociception Produced by 14,15-Epoxyeicosatrienoic Acid Is Mediated by the Activation of {beta}-Endorphin and Met-Enkephalin in the Rat Ventrolateral Periaqueductal Gray
J. Pharmacol. Exp. Ther., August 1, 2008; 326(2): 614 - 622.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Y. Cheranov, M. Karpurapu, D. Wang, B. Zhang, R. C. Venema, and G. N. Rao
An essential role for SRC-activated STAT-3 in 14,15-EET-induced VEGF expression and angiogenesis
Blood, June 15, 2008; 111(12): 5581 - 5591.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
G. Yan, S. Chen, B. You, and J. Sun
Activation of sphingosine kinase-1 mediates induction of endothelial cell proliferation and angiogenesis by epoxyeicosatrienoic acids
Cardiovasc Res, May 1, 2008; 78(2): 308 - 314.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
G. Irusta, M.J. Murphy, W.D. Perez, and J.D. Hennebold
Dynamic expression of epoxyeicosatrienoic acid synthesizing and metabolizing enzymes in the primate corpus luteum
Mol. Hum. Reprod., August 1, 2007; 13(8): 541 - 548.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Pozzi, M. R. Ibanez, A. E. Gatica, S. Yang, S. Wei, S. Mei, J. R. Falck, and J. H. Capdevila
Peroxisomal Proliferator-activated Receptor-{alpha}-dependent Inhibition of Endothelial Cell Proliferation and Tumorigenesis
J. Biol. Chem., June 15, 2007; 282(24): 17685 - 17695.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Rao, R. Redha, I. Macias-Perez, Y. Su, C. Hao, R. Zent, M. D. Breyer, and A. Pozzi
Prostaglandin E2-EP4 Receptor Promotes Endothelial Cell Migration via ERK Activation and Angiogenesis in Vivo
J. Biol. Chem., June 8, 2007; 282(23): 16959 - 16968.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
C. Morin, M. Sirois, V. Echave, M. M. Gomes, and E. Rousseau
Epoxyeicosatrienoic Acid Relaxing Effects Involve Ca2+-Activated K+ Channel Activation and CPI-17 Dephosphorylation in Human Bronchi
Am. J. Respir. Cell Mol. Biol., May 1, 2007; 36(5): 633 - 641.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
A. A. Spector and A. W. Norris
Action of epoxyeicosatrienoic acids on cellular function
Am J Physiol Cell Physiol, March 1, 2007; 292(3): C996 - C1012.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
S. Diani-Moore, F. Papachristou, E. Labitzke, and A. B. Rifkind
INDUCTION OF CYP1A AND CYP2-MEDIATED ARACHIDONIC ACID EPOXYGENATION AND SUPPRESSION OF 20-HYDROXYEICOSATETRAENOIC ACID BY IMIDAZOLE DERIVATIVES INCLUDING THE AROMATASE INHIBITOR VOROZOLE
Drug Metab. Dispos., August 1, 2006; 34(8): 1376 - 1385.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. Dhanasekaran, R. Al-Saghir, B. Lopez, D. Zhu, D. D. Gutterman, E. R. Jacobs, and M. Medhora
Protective effects of epoxyeicosatrienoic acids on human endothelial cells from the pulmonary and coronary vasculature
Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H517 - H531.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
I. Fleming and R. Busse
Endothelium-Derived Epoxyeicosatrienoic Acids and Vascular Function
Hypertension, April 1, 2006; 47(4): 629 - 633.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.